Detection and significance of minority quasispeci... [J HIV Ther. 2006] - PubMed

Save items

loading

Related citations in PubMed

Selected topics from the 8th Conference on Retroviruses and Opportunistic Infections. February 4-8, 2001. Chicago, Illinois. [HIV Clin Trials. 2001]
Selected topics from the 8th Conference on Retroviruses and Opportunistic Infections. February 4-8, 2001. Chicago, Illinois.
Kuritzkes DR. HIV Clin Trials. 2001 May-Jun; 2(3):219-26.
Clinical utility of resistance testing. [J HIV Ther. 2002]
Clinical utility of resistance testing.
Stebbing J, Gazzard BG. J HIV Ther. 2002 Nov; 7(4):75-9.
Review Minority variants of drug-resistant HIV. [J Infect Dis. 2010]
Review Minority variants of drug-resistant HIV.
Gianella S, Richman DD. J Infect Dis. 2010 Sep 1; 202(5):657-66.
Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naïve populations and associate with reduced treatment efficacy. [PLoS Med. 2008]
Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naïve populations and associate with reduced treatment efficacy.
Johnson JA, Li JF, Wei X, Lipscomb J, Irlbeck D, Craig C, Smith A, Bennett DE, Monsour M, Sandstrom P, et al. PLoS Med. 2008 Jul 29; 5(7):e158.
Review Low-frequency HIV-1 drug resistance mutations can be clinically significant but must be interpreted with caution. [J Antimicrob Chemother. 2010]
Review Low-frequency HIV-1 drug resistance mutations can be clinically significant but must be interpreted with caution.
Johnson JA, Geretti AM. J Antimicrob Chemother. 2010 Jul; 65(7):1322-6. Epub 2010 May 13.

See reviews... See all...

Cited by 2 PubMed Central articles

Prevalence and impact of minority variant drug resistance mutations in primary HIV-1 infection. [PLoS One. 2011]
Prevalence and impact of minority variant drug resistance mutations in primary HIV-1 infection.
Stekler JD, Ellis GM, Carlsson J, Eilers B, Holte S, Maenza J, Stevens CE, Collier AC, Frenkel LM. PLoS One. 2011; 6(12):e28952. Epub 2011 Dec 16.
Reappearance of minority K103N HIV-1 variants after interruption of ART initiated during primary HIV-1 infection. [PLoS One. 2011]
Reappearance of minority K103N HIV-1 variants after interruption of ART initiated during primary HIV-1 infection.
Metzner KJ, Leemann C, Di Giallonardo F, Grube C, Scherrer AU, Braun D, Kuster H, Weber R, Guenthard HF. PLoS One. 2011; 6(7):e21734. Epub 2011 Jul 6.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Detection and significance of minority quasispecies of drug-resistant HIV-1.
Detection and significance of minority quasispecies of drug-resistant HIV-1.
J HIV Ther. 2006 Dec ;11(4):74-81.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Detection and significance of minority quasispecies of drug-resistant HIV-1.

Source

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Other Literature Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Cited by 2 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information